This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Vision-Sciences' EndoSheath(R) Technology Offers Patented Solution To "Nightmare Bacteria"

ORANGEBURG, N.Y., Jan. 13, 2014 (GLOBE NEWSWIRE) -- An outbreak of "Nightmare Bacteria," also known as the "Super Bug," has raised new alarm bells in the healthcare industry over patient safety. The concern stems from 44 newly reported cases of cross-contamination infections as a result of endoscopic procedures done at Advocate Lutheran General Hospital, located just outside of Chicago.*

"This type of outbreak not only undermines patient confidence, it creates stiff potential financial liabilities for hospitals and other healthcare facilities under the Affordable Care Act," said Howard Zauberman, President and Chief Executive Officer of Vision-Sciences, Inc. (Nasdaq:VSCI) – a company specializing in endoscopes that help safeguard patients from cross-contamination infections caused by conventional endoscopes.

Vision-Sciences ( www.visionsciences.com ) provides patented technology solutions that safeguard patients with a sterile cover, or EndoSheath® Technology , for its endoscopes. This prevents direct contact of the scope with the patient and reduces the risk of contracting infections from bacteria such as the Nightmare Bacteria as a result of endoscopic cross-contamination. In 20 years and with over 5 million procedures performed with EndoSheath® Technology, Vision-Sciences has never received a report of cross-contamination.

"We feel confident that our EndoSheath® Technology is a win-win for the healthcare facility and its patients. It is in our best interest to ensure that all healthcare professionals are aware of this alternative to conventional endoscopes while offering a cost cutting and liability reducing solution," said Lewis C. Pell, Chairman and Co-founder of Vision-Sciences.

Mr. Pell and Mr. Zauberman are available for in-person meetings or phone interviews. Please contact Mitch Kayden at (845) 709-5607 for more information and to set up an interview.

Important Summary Points

-- The Affordable Care Act creates potential liability for all healthcare facilities for hospital-acquired infections. Vision Sciences® technology offers an option for hospitals to reduce liability and lower costs/overhead.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs